Seeking Alpha

Sequenom reiterated at Buy at Maxim

  • Sequenom (SQNM -0.2%) gets a vote of confidence from Maxim's Bryan Brokmeier who reiterates the shares at Buy following the company's Q3 results.
  • "The reimbursement environment remains challenging [but] we're increasingly optimistic," Brokmeier notes, citing the percentage of diagnostic revenue from international, the Q/Q rise in covered lives, and the fact that "all major national payers are reimbursing the MaterniT21."
  • Price target is $6.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector